Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis
Danazol treatment significantly increased insulin and glucagon levels in women with endometriosis, while goserelin did not, and the increased free testosterone index from danazol was not correlated with these hormonal changes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (7)
- Traitements des localisations urologiques de l'endométriose 2009
- Ovulation suppression for endometriosis for women with subfertility 2007
- Ovulation suppression for endometriosis 2003
- WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
- Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders 1996
- Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover 1995
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:47.456808+00:00